These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8092834)

  • 1. Antagonistic effects of fluconazole and 5-fluorocytosine on candidacidal action of amphotericin B in human serum.
    Martin E; Maier F; Bhakdi S
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1331-8. PubMed ID: 8092834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.
    Ernst EJ; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):205-10. PubMed ID: 9884837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Candida albicans, Austria 1992.
    Allerberger F; Fassl A; Niederwieser D; Zangerle R; Lingnau W; Dierich MP
    Mycoses; 1993; 36(11-12):411-6. PubMed ID: 7935573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5-fluorocytosine.
    Richardson MD; Paton M; Shankland GS
    Mycoses; 1991; 34(5-6):201-4. PubMed ID: 1795714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
    Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
    Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
    van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong correlation between the antifungal effect of amphotericin B and its inhibitory action on germ-tube formation in a Candida albicans URA⁺ strain.
    Guirao-Abad JP; González-Párraga P; Argüelles JC
    Int Microbiol; 2015 Mar; 18(1):25-31. PubMed ID: 26415664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
    Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.
    Lewis RE; Lund BC; Klepser ME; Ernst EJ; Pfaller MA
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1382-6. PubMed ID: 9624480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
    Ellepola AN; Samaranayake LP
    Oral Dis; 1998 Dec; 4(4):260-7. PubMed ID: 10200705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
    J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of human serum on the postantifungal effect of four antifungal agents on Candida albicans.
    Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1996; 42(4):273-9. PubMed ID: 8804795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric assay for estimating fungicidal activity of amphotericin B in human serum.
    Martin E; Schlasius U; Bhakdi S
    Med Microbiol Immunol; 1992; 181(3):117-26. PubMed ID: 1522821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents.
    Waltimo TM; Ørstavik D; Meurman JH; Samaranayake LP; Haapasalo MP
    Oral Microbiol Immunol; 2000 Aug; 15(4):245-8. PubMed ID: 11154410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of fluconazole-amphotericin B antagonism to Candida albicans by agar diffusion.
    Scheven M; Senf L
    Mycoses; 1994; 37(5-6):205-7. PubMed ID: 7898518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.